--- title: "10:26 ET\n\t\t\t\n\t\t\t\n\t\t\t\tLFMD 13-DAY DEADLINE ALERT: Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman" description: "A federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging misleading statements about its financial health and growth prospects. The lawsuit follows a sign" type: "news" locale: "en" url: "https://longbridge.com/en/news/261098127.md" published_at: "2025-10-14T14:27:13.000Z" --- # 10:26 ET LFMD 13-DAY DEADLINE ALERT: Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman > A federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging misleading statements about its financial health and growth prospects. The lawsuit follows a significant stock price drop after the company's earnings report in August. Investors are encouraged to contact Hagens Berman before the October 27 deadline to recover losses incurred between May 7 and August 5, 2025. The suit claims LifeMD failed to disclose rising customer acquisition costs and refund issues, leading to a 44% stock price decline after disappointing second-quarter results. LFMD Investors with Losses Encouraged to Contact the Firm Before Oct. 27th Deadline , /PRNewswire/ -- A new federal securities fraud class action lawsuit has been filed against **LifeMD (NASDAQ: LFMD)**, alleging that the telehealth company and its executives provided investors with a misleading picture of its financial health and growth prospects. The suit, filed in in the Eastern District of New York, comes after a dramatic stock price decline in August following the company's earnings report. The firm urges investors in LifeMD who suffered significant losses to submit your losses now. **Class Period:** May 7, 2025 – Aug. 5, 2025 **Lead Plaintiff Deadline:** Oct. 27, 2025 **Visit:**www.hbsslaw.com/investor-fraud/lfmd **Contact the Firm Now:** \[email protected\] **844-916-0895** **LifeMD, Inc. (LFMD) Securities Class Action:** The lawsuit, captioned *Johnston v. LifeMD, Inc.*, focuses on the period between May 7 and August 5, 2025. It alleges that LifeMD made false and misleading statements, particularly on May 6, 2025, when it reported its first-quarter results and raised its full-year revenue and adjusted EBITDA guidance. The complaint claims that the company's optimistic outlook, which cited a "category-defining competitive moat" in virtual obesity care and strong performance from its RexMD brand, was false as it misleadingly failed to account for crucial business challenges. The suit contends that LifeMD was experiencing rising customer acquisition costs in its RexMD segment and a higher-than-anticipated refund rate in its weight management business, issues that it did not disclose to investors at the time. The alleged deception unraveled on August 5, 2025, when LifeMD announced its second-quarter results, missing revenue and earnings per share estimates and subsequently slashing its full-year guidance. During the earnings call, management cited "temporary elevated customer acquisition costs" for its RexMD business and issues with patient refunds for its weight management offerings. The following day, LifeMD's stock price plummeted by over 44%. For investors who suffered substantial losses during this period, the lawsuit represents an opportunity to recover damages. **Hagens Berman's Investigation** Hagens Berman, a national plaintiffs' rights firm, is investigating these claims. "We're investigating whether LifeMD knew of but failed to disclose key operational problems," said Reed Kathrein, the Hagens Berman partner leading the investigation. If you invested in LifeMD and have substantial losses, or have knowledge that may assist the firm's investigation, submit your losses now » If you'd like more information and answers to frequently asked questions about the LifeMD case and our investigation, read more » **Whistleblowers:** Persons with non-public information regarding LifeMD should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at **844-916-0895** or email \[email protected\]. About Hagens Berman Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. SOURCE Hagens Berman Sobol Shapiro LLP ### Related Stocks - [LFMD.US - LifeMD](https://longbridge.com/en/quote/LFMD.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Lake Street 繼續維持對 LifeMD（LFMD）的買入評級 | Lake Street 的 Ryan Meyers 對 LifeMD 維持買入評級，目標價為 8.00 美元。這位分析師覆蓋消費週期性行業，平均回報率為-7.0%，成功率為 34.20%。對於 LifeMD 的整體分析師共識為強烈買入，平均 | [Link](https://longbridge.com/en/news/270855288.md) | | LifeMD 從 Citizens Bank 獲得了 5000 萬美元的循環信貸額度 | LifeMD Inc. 已從公民銀行獲得了一項 5000 萬美元的循環信貸額度，其中包括 3000 萬美元的承諾資金和 2000 萬美元的可調選項。該信貸額度將於 2029 年 1 月 2 日到期，並提供具有競爭力的資本，且沒有前期費用。L | [Link](https://longbridge.com/en/news/271657692.md) | | 馬斯克宣布 xAI 重組及員工離職 稱「快速增長所必需」 | 馬斯克宣布 xAI 重組，涉及員工離職，稱這是公司快速增長所必需。xAI 與 SpaceX 合併後，重組將公司分為四個主要團隊，專注於 AI 聊天機器人 Grok、編程 AI 模型、圖像生成模型及 Macrohard 項目。儘管成立較晚，x | [Link](https://longbridge.com/en/news/275716620.md) | | 樂欣户外據報上限 12.25 元定價 愛芯元智傳 50 手中 1 手 | 樂欣户外（2720）以招股上限 12.25 元定價，認購 2820 手未能穩中一手。愛芯元智（600）認購 50 手穩中一手。先導智能（470）以招股價上限 45.8 元定價，悉數行使發售量調整權。瀾起科技（6809）收市漲 39.8% 至 | [Link](https://longbridge.com/en/news/275188113.md) | | 馬斯克稱 SpaceX 重心轉移月球 料 10 年內建「可自我發展城市」 | SpaceX 執行長馬斯克宣佈，公司重心轉向在月球建立「可自我發展的城市」，預計在 10 年內實現。儘管計劃在 5 至 7 年內啟動相關工作，但他強調保障人類文明未來是首要任務，月球登陸是更快的途徑。同時，SpaceX 已同意收購 AI 初 | [Link](https://longbridge.com/en/news/275255028.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.